QPEX BIOPHARMA
Qpex Biopharma develops a pipeline of agents addressing critical needs for the treatment of infectious diseases. It develops multiple antibiotic drugs intended to combat antimicrobial resistance. The company's technology is focused on targeting the treatment of infectious diseases for both inpatient and outpatient cases, deep expertise in the discovery, development and regulatory approval of anti-infective medicines, including an extensive record of working with public/private partnerships focused on new antibiotics to combat antimicrobial resistance, enabling medical businesses optimal use of products and critical needs for the treatment of infectious diseases in the inpatient and outpatient settings. It was founded in 2018 and is headquartered in San Diego, California.
QPEX BIOPHARMA
Industry:
Biotechnology Health Care
Founded:
2018-10-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.qpexbio.com
Total Employee:
11+
Status:
Active
Contact:
858.500.8366
Total Funding:
53 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Domain Not Resolving Euro Microsoft Exchange Online Office 365 Mail
Current Employees Featured
Michelle Linfesty Vice President, Program Management @ Qpex Biopharma
Vice President, Program Management
Michael Dudley President and CEO @ Qpex Biopharma
President and CEO
2018-10-01
Wendy Roos Vice President of Finance, Administration and Controller @ Qpex Biopharma
Vice President of Finance, Administration and Controller
Jeffery Loutit Chief Medical Officer @ Qpex Biopharma
Chief Medical Officer
2018-10-01
Paul Westberg Chief Business Officer @ Qpex Biopharma
Chief Business Officer
2020-11-01
Jeffery Loutit Chief Medical Officer @ Qpex Biopharma
Chief Medical Officer
Scott Hecker Sr. Vice President, Chemistry & Chemical Development @ Qpex Biopharma
Sr. Vice President, Chemistry & Chemical Development
2018-10-01
Olga Lomovskaya Senior Vice Presedent, Discovery and Clinical Microbiology @ Qpex Biopharma
Senior Vice Presedent, Discovery and Clinical Microbiology
2021-03-01
Founder
Investors List
Biomedical Advanced Research and Development Authority (BARDA)
Biomedical Advanced Research and Development Authority (BARDA) investment in Grant - Qpex Biopharma
LYZZ Capital
LYZZ Capital investment in Series A - Qpex Biopharma
Hatteras Venture Partners
Hatteras Venture Partners investment in Series A - Qpex Biopharma
New Enterprise Associates
New Enterprise Associates investment in Series A - Qpex Biopharma
Adams Street Partners
Adams Street Partners investment in Series A - Qpex Biopharma
Stanford University
Stanford University investment in Series A - Qpex Biopharma
Official Site Inspections
http://www.qpexbio.com Semrush global rank: 4.4 M Semrush visits lastest month: 2.54 K
- Host name: ec2-44-196-8-221.compute-1.amazonaws.com
- IP address: 44.196.8.221
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Qpex Biopharma"
Company - Qpex Biopharma
This brought together our novel pipelines and experienced and specialized team of infectious disease researchers with over 25 years of innovation with an established global R&D …See details»
Qpex Biopharma - Crunchbase Company Profile
Qpex Biopharma develops a pipeline of agents addressing critical needs for the treatment of infectious diseases. It develops multiple antibiotic drugs intended …See details»
Shionogi Further Extends Infectious Disease Innovation Platform …
Jun 26, 2023 “Qpex is thrilled to become part of Shionogi, a world-class organization with an established legacy and commitment to innovation in the development of products for the …See details»
Qpex Biopharma - LinkedIn
Qpex Biopharma, Inc. a Shionogi Group Company, is a resistance-focused infectious disease company on a mission to make both a dramatic and sustainable improvement in patient care.See details»
Qpex Biopharma - Craft
Qpex Biopharma has 5 employees at their 1 location and $53 m in total funding,. See insights on Qpex Biopharma including office locations, competitors, revenue, financials, executives, …See details»
QPEX BIOPHARMA, INC. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for QPEX BIOPHARMA, INC. of San Diego, CA. Get the latest business insights from Dun & Bradstreet.See details»
Qpex 2025 Company Profile: Valuation, Investors, …
Qpex General Information Description. Operator of a biopharmaceutical company intended to discover and develop anti-infective therapies. The company is focused on targeting the treatment of infectious diseases for both inpatient …See details»
Qpex Biopharma, Inc. - Drug pipelines, Patents, Clinical trials
Advancing a robust portfolio of best-in-class, clinical-stage products, the company’s lead program is based on xeruborbactam, an investigational beta-lactamase inhibitor discovered by Qpex …See details»
Qpex Biopharma | Developing New Antibiotics | San …
Developing innovative products through novel strategies for infectious diseases. With a focus on understanding and overcoming resistance mechanisms, we will make prominent, sustainable improvements in patient care across both …See details»
Shionogi Further Extends Infectious Disease Innovation Platform …
Jun 26, 2023 “Qpex is thrilled to become part of Shionogi, a world-class organization with an established legacy and commitment to innovation in the development of products for the …See details»
Qpex Biopharma - Overview, News & Similar companies - ZoomInfo
Oct 17, 2022 Qpex Biopharma Announces Progress on Three Clinical Stage Programs for Antibiotic-Resistant Pathogens and Corporate Update SAN DIEGO--(BUSINESS WIRE)- …See details»
Qpex Biopharma - VentureRadar
Acurx Pharmaceuticals, LLC USA n/a Acurx Pharmaceuticals, Inc. is a publicly held, clinical-stage biopharmaceutical company focused on developing a new class of antibiotics targeting …See details»
Leadership - Qpex Biopharma
Our leadership team has a proven track record of discovering novel compounds that target bacteria that are resistant to available anti-infectives.See details»
Qpex Biopharma, Inc. (Qpex Biopharma, Inc.) - 药物管线_专利_临 …
Mar 6, 2025 Advancing a robust portfolio of best-in-class, clinical-stage products, the company’s lead program is based on xeruborbactam, an investigational beta-lactamase inhibitor …See details»
Mission - Qpex Biopharma
Our mission is to meet the urgent need for safe and more potent anti-infectives that are not affected by multidrug resistance mechanisms.See details»
Qpex Biopharma, a Shionogi Group Company, Receives an …
May 31, 2024 For more information, please visit www.qpexbio.com and follow us on Twitter and LinkedIn. About Qpex and BARDA Partnership Qpex scientists and clinicians have an …See details»
Qpex Biopharma Announces Progress on Three Clinical Stage
Jan 19, 2022 SAN DIEGO--(BUSINESS WIRE)-- QPex Biopharma (Qpex) a clinical-stage biopharmaceutical company discovering and developing innovative anti-infective therapies, …See details»
News | Qpex Strengthens Leadership Team and Provides Update …
Jan 5, 2021 Qpex has a multi-product collaboration with Brii Biosciences for the development and commercialization of three of its products in greater China. For more information, please …See details»
News | Qpex Announces - Qpex Biopharma
Jan 19, 2022 SAN DIEGO, June 17, 2021 – Qpex Biopharma, Inc., (Qpex) a resistance-focused clinical-stage biopharmaceutical company discovering and developing innovative anti-infective …See details»
Partnering - Qpex Biopharma
Our scientists and clinicians have an extensive track record of successfully working in public-private partnerships, including a partnership with the Biomedical Advanced Research and …See details»